Followers | 53 |
Posts | 7442 |
Boards Moderated | 0 |
Alias Born | 08/24/2010 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, August 14, 2019 9:26:38 AM
by Arlene Weintraub | Aug 12, 2019 9:35am
Pancreatic cancer
Reducing perlecan in mouse models of pancreatic cancer slowed metastasis and improved the response to chemotherapy. (By Manu5, via Wikimedia Commons)
Pancreatic cancer is one of the toughest forms of the disease to treat, because it often causes no symptoms until it has spread beyond the pancreas. Now, a team led by the Garvan Institute of Medical Research in Australia has discovered one method by which pancreatic cancer cells spread and shield themselves from chemotherapy—a finding that could provide a new two-pronged approach to treating the disease, they said.
The researchers discovered that some pancreatic tumors overproduce perlecan, a type of protein that helps cancer cells change the “cellular matrix”—the tissue that holds tumors together. That remodeling of the tumor's environment allows cancer cells to travel to other parts of the body. The perlecan also seems to protect the cells from chemotherapy.
The team lowered levels of perlecan in mouse models of pancreatic cancer and observed a drop in the spread of the cancer and an improvement in the response to chemotherapy. They reported their findings in the journal Nature Communications.
Rest of the story:
https://www.fiercebiotech.com/research/stopping-spread-pancreatic-cancer?mkt_tok=eyJpIjoiT0RkaE56UmhOR1EwWmpFeCIsInQiOiI1RkJRSUk4VEJld0ZkdXJjd2o2amJzR0JcL21cL2R1V1F6YVdVVmtiMTlqdzV1bFpXZWloUWgyVDMzNTI4WU8rVlpCQjBGd2E3VlNTNDJOdmNrbitHVGZUbVFSQXlabmVzUkltXC81Tk9iakVMNm1uVThWdHVoSWU0ZzcxN3gwemw1RyJ9&mrkid=68926271
Also This:
https://www.fiercebiotech.com/biotech/deciphera-soars-as-phase-3-cancer-data-tee-up-fda-filing?mkt_tok=eyJpIjoiWmpFNU5EQmpabVE1T0RjNSIsInQiOiJjaEk5eWNPNWt2ZXdLZlwvemREb0o2ajhzMGhmc0h0cjZKSUNBcGtzRFZ2WTl5VldnMDRJbm9qbUxVMlEwY0xzb25TVkxiNVBKUUltTzhIQTJhWk01ZzlvcEJSU3BwXC91clZuSWxZUDUyTzh5dDl3d05RVXhUZUlkMTNzb2hMcTFCIn0%3D&mrkid=68926271
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM